Cited by 41Alzheimer's disease research and treatmentsMolecular Sensors and Ion DetectionCholinesterase and Neurodegenerative Diseases

Synthesis and characterization of IMPY derivatives that regulate metal-induced amyloid-β aggregation

Choi, Jung-Suk, Braymer, Joseph J., Park, Se Kyung, Mustafa, Shaik, Chae, Junghyun, Lim, Mi Hee·2011·Metallomics

Abstract

Metal ions associated with amyloid-β (Aβ) species have been suggested to be involved in neurodegeneration leading to the progression of Alzheimer's disease (AD). The role of metal-involved Aβ species in AD neuropathogenesis, however, is not fully elucidated. In order to advance this understanding and contribute to the therapeutic development for AD, the rational structure-based design of small molecules that specifically target metal ions surrounded by Aβ species has recently received increased attention. To date, only a few compounds have been fashioned for this purpose. Herein, we report the design strategy, synthesis, characterization, and reactivity of new bifunctional IMPY derivatives K1 and K2. Using UV-vis and high-resolution two-dimensional (2D) NMR spectroscopy, the bifunctionality of K1 and K2 (metal chelation and Aβ interaction) was confirmed. These bifunctional IMPY derivatives showed preferential reactivity toward metal-induced Aβ aggregation over metal-free conditions in both in vitro inhibition and disaggregation experiments. Taken together, this study provides another example of a bifunctional small molecule framework that can target metal ions associated with Aβ species.

Integrity signals

Registry

Crossref · 10.1039/c0mt00077a

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Two approaches have been pursued in BFC design: direct incorporation of metal-binding atom donors into the structural framework of an Aβ-interacting compound, and linking the metal-chelating and Aβ-binding molecular fragments.

    “In this context, two approaches have been pursued in BFC design. 31,49–58 One strategy is based on the direct incorporation of metal-binding atom donors into the structural framework of an Aβ-interacting compoud (Scheme 1, approach A), and the other involves linking the metal-chelating and Aβ-binding molecular fragments (Scheme 1, approach B).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Choi, J.-S., Braymer, J. J., Park, S. K., Mustafa, S., Chae, J., & Lim, M. H.
Affiliations
  • University of Michigan (US)
  • Sungshin Women's University (KR)
Corresponding author
  • Chae, Junghyun
  • Lim, Mi Hee
Venue
Metallomics
Published
2011
Volume
3
Issue
3
Pages
284
ISSN
  • 1756-5901 (ISSN-L)
  • 1756-591X
OpenAlex
W2045704153
Cited by
41
References
45
Citations by year
2025: 1 · 2024: 4 · 2022: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 6 · 2013: 4 · 2012: 7
FWCI
4.80
Type
journal article
Language
en
Open access
closed
Locations
  • Metallomics (publishedVersion)
  • PubMed (publishedVersion)
  • Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
  • Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
Keywords
amyloid-beta aggregation, metal ions, Alzheimer's disease, metal chelation, bifunctional small molecules, structure-based drug design
MeSH terms
Alzheimer Disease, Chelating Agents, Humans, Metals, Pyrazoles, Pyridines, Drug Design, Amyloid beta-Peptides

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review